 Cell cycling bladder carcinoma monoclonal antibody Current methods prognosis transitional cell carcinoma bladder fail reliable information future tumour behaviour monoclonal antibody antigen present cells reactivity conventional prognostic indicators several tumours study antibody proportions cells active division transitional cell carcinomas bladder proportion cells muscle invasive tumours superficial tumours tumours proportions cells differentiated tumours results reactivity high tumour stage poor differentiation easy method tumour cell turnover additional prognostic information